Skip to main content
. Author manuscript; available in PMC: 2020 Jan 24.
Published in final edited form as: Subst Abus. 2019 Jan 24;40(3):292–301. doi: 10.1080/08897077.2018.1545726

Table 4.

Among patients identified with an alcohol or drug use disorder (AOD) in an inpatient setting who initiated AOD treatment (N=16,193), characteristics associated with AOD treatment engagement

Characteristic associated with AOD treatment engagement Identified in inpatient setting (N=16193) N (%) or Median (IQR) Unadjusted RR for AOD engagement (95% CI) Adjusted RR for AOD engagement (95% CI)
Race/ethnicity
White 10012 (61.8) [Ref] [Ref]
Asian 549 (3.4) 1.10 (0.78–1.55) 1.22 (0.85–1.76)
African American 1941 (12.0) 0.61 (0.47–0.78) 0.68 (0.56–0.82)
Hispanic 2732 (16.9) 0.97 (0.88–1.08) 1.02 (0.93–1.13)
Other/Unknown 959 (5.9) 1.07 (0.84–1.36) 1.13 (0.91–1.42)

Age 53.0 (19.0) 0.98 (0.98–0.99) --

Sex
Male 9471 (58.5) [Ref] [Ref]
Female 6722 (41.5) 0.91 (0.78–1.08) 0.91 (0.77–1.08)

Charlson/Deyo comorbidity index
0 6043 (37.3) [Ref] [Ref]
1 3273 (20.2) 0.95 (0.84–1.07) 0.90 (0.79–1.02)
2+ 6877 (42.5) 0.73 (0.64–0.83) 0.70 (0.61–0.79)

Diagnoses in the prior year

 Alcohol Dependence 3843 (23.7) 2.68 (2.28–3.16) 2.70 (2.23–3.26)

 Drug Dependence 2998 (18.5) 1.96 (1.79–2.15) --

 Depressive Disorder 6093 (37.6) 1.45 (1.31–1.62) 1.37 (1.23–1.52)

 Major Psychotic Disorder 2823 (17.4) 1.59 (1.31–1.92) 1.47 (1.15–1.88)

 Tobacco Dependence 5070 (31.3) 1.51 (1.35–1.68) --

 Hepatitis C 588 (3.6) 1.44 (1.10–1.86) --

 Pancreatic Disease 971 (6.0) 1.58 (1.44–1.74) --

Abbreviations. IQR=interquartile range; RR = risk ratio; CI = confidence interval; AOD=alcohol or other drugs; -- indicates variables not included in adjusted analyses because they either were not significant in bivariate analyses (p-value ≥ 0.25) or forward selection modeling (p-value ≥ 0.25)